SEC Form 3 filed by new insider Sturchio Edward A Jr
$IMTX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Date of Event Requiring Statement
(Month/Day/Year) 03/18/2026 | 3. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ] | |||||||||||||||
| 3a. Foreign Trading Symbol
| 5. If Amendment, Date of Original Filed
(Month/Day/Year) | ||||||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (Right to Buy) | (1) | 06/30/2030 | Ordinary Shares | 30,000 | $10 | D | |
| Stock Option (Right to Buy) | (2) | 06/30/2030 | Ordinary Shares | 36,000 | $10 | D | |
| Stock Option (Right to Buy) | (1) | 12/17/2030 | Ordinary Shares | 30,000 | $9.68 | D | |
| Stock Option (Right to Buy) | (3) | 09/27/2031 | Ordinary Shares | 100,000 | $12.92 | D | |
| Stock Option (Right to Buy) | (1) | 09/27/2031 | Ordinary Shares | 30,000 | $12.92 | D | |
| Stock Option (Right to Buy) | (1) | 12/08/2031 | Ordinary Shares | 30,000 | $11 | D | |
| Stock Option (Right to Buy) | (4) | 12/12/2032 | Ordinary Shares | 60,000 | $9.75 | D | |
| Stock Option (Right to Buy) | (5) | 09/12/2033 | Ordinary Shares | 52,500 | $11.87 | D | |
| Stock Option (Right to Buy) | (6) | 12/04/2033 | Ordinary Shares | 115,000 | $9.06 | D | |
| Stock Option (Right to Buy) | (7) | 12/02/2034 | Ordinary Shares | 110,000 | $8.06 | D | |
| Stock Option (Right to Buy) | (8) | 01/07/2036 | Ordinary Shares | 160,000 | $9.32 | D | |
| Restricted Stock Units | (9) | (9) | Ordinary Shares | 40,000 | $0 | D | |
| Explanation of Responses: |
| 1. These options to purchase ordinary shares of the Issuer ("Ordinary Shares," and each such option, an "Option") are fully vested. |
| 2. These Options are eligible to be earned based on the achievement of specified market capitalization performance hurdles and service-vesting conditions. The service-vesting conditions are satisfied as to 25% of the Options on the first anniversary of the grant date, June 30, 2020, and 6.25% of the Options on each quarterly anniversary of such date over the following three years. |
| 3. These Options are eligible to be earned based on the achievement of specified market capitalization performance hurdles and service-vesting conditions. The service-vesting conditions are satisfied as to 25% of the Options on the first anniversary of the grant date, September 28, 2021, and 6.25% of the Options on each quarterly anniversary of such date over the following three years. |
| 4. These Options vest 25% on the first anniversary of the grant date, December 13, 2022, then in 12 equal quarterly installments over the following three years. |
| 5. These Options vest 25% on the first anniversary of the grant date, September 13, 2023, then in 12 equal quarterly installments over the following three years. |
| 6. These Options vest 25% on the first anniversary of the grant date, December 5, 2023, then in 12 equal quarterly installments over the following three years. |
| 7. These Options vest 25% on the first anniversary of the grant date, December 3, 2024, then in 12 equal quarterly installments over the following three years. |
| 8. These Options vest 25% on the first anniversary of the grant date, January 8, 2026, then in 12 equal quarterly installments over the following three years. |
| 9. Each restricted stock unit ("RSU") represents a contingent right to receive one Ordinary Share. These RSUs vest in four equal annual installments on each anniversary of the grant date, January 8, 2026. |
| Remarks: |
| Exhibit List - Exhibit 24.1 - Power of Attorney |
| /s/ Edward Sturchio | 03/18/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 3: SEC 1473 (03-26) | ||